HOME NEWS EARNINGS RESULTS PICKS STRATEGY BLOG CONTACT SUBSCRIBE LOGIN SUBSCRIBE JOIN FREE
LOADING
Price Investing Group
← Back to Research Watchlist
QURE
uniQure N.V.
Healthcare Biotechnology · Netherlands · Reports in usd
Market Cap: $1.69B
Market Cap
$1.69B
Enterprise Val
$1.65B
P/E Ratio
-8.10
P/B Ratio
11.33
Trailing PEG (1Y)
-2.21
As Of
May 14, 2026

Overview & Key Metrics

Reporting period: Mar 31, 2026 · Q1 2026
Book Value$149.3M
Gross Margin93.85%
Profit Margin93.85%
Return on Equity-145.81%
Return on Assets-27.15%
Current Ratio10.40
Debt/Equity3.65
LT Debt/Equity3.63
Revenue Per Share0.06

Income Statement

Mar 31, 2026
Revenue$3.6M
Cost of Revenue$219.0K
Gross Profit$3.3M
R&D$29.2M
SG&A$20.1M
Operating Expenses$49.1M
Operating Income-$45.7M
Interest Expense$14.0M
Tax Expense$488.0K
Net Income-$53.5M
EPS (Basic)$-0.85
EPS (Diluted)$-0.85
EBIT-$39.0M
EBITDA-$36.1M
Consolidated Income-$53.5M
Non-Controlling Interests$0.00

Balance Sheet

Mar 31, 2026
Cash & Equivalents$140.0M
Accounts Receivable$3.6M
Inventory$0.00
Current Assets$615.7M
LT Investments$30.2M
Property, Plant & Equipment$24.3M
Intangibles$94.8M
Non-Current Assets$163.0M
Total Assets$778.7M
Accounts Payable$4.4M
Current Debt$3.0M
Current Liabilities$59.2M
LT Debt$542.7M
Non-Current Liabilities$570.2M
Total Liabilities$629.4M
Total Debt$545.7M
Retained Earnings-$1.38B
Shareholder Equity$149.3M
Shares Outstanding62,529,408

Cash Flow Statement

Mar 31, 2026
Operating Cash Flow-$38.2M
Investing Cash Flow$98.6M
Financing Cash Flow$550.0K
CapEx-$140.0K
Free Cash Flow-$38.4M
Depreciation & Amort.$3.0M
Stock-Based Comp$5.1M
Acquisitions / Disposals$0.00
Investment Activity$98.7M
Debt Issued/Repaid$0.00
Equity Issued/Repaid$550.0K
Dividends Paid$0.00
Net Change in Cash$59.7M
Data cached · Meta cache · Daily cache · Statements cache · TTL 24h